Volume 21; Issue 5

Main
PharmacoEconomics
Volume 21; Issue 5

PharmacoEconomics

Volume 21; Issue 5

1

Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease

Wimo, Anders, Winblad, Bengt, Stoffler, Albrecht, Wirth, Yvonne, Mobius, Hansjorg

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 177 KB

english, 2003

2

Cost Effectiveness of Alendronate (Fosamax®) for the Treatment of Osteoporosis and Prevention of Fractures

Johnell, Olof, J??nsson, Bengt, J??nsson, Linus, Black, Dennis

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 187 KB

english, 2003

3

Cost Effectiveness of Nasal Budesonide versus Surgical Treatment for Nasal Polyps

Berggren, Fredrik, Johansson, Leif

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 119 KB

english, 2003

4

Peginterferon α-2a (40kD) [Pegasys®] Improves HR-QOL Outcomes Compared with Unmodified Interferon α-2a [Roferon®-A]

Dr Jens Rasenack,Stefan Zeuzem,S. Victor Feinman,E. Jenny Heathcote…

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 134 KB

english, 2003

5

A Simulation Model for Estimating Direct Costs of Type 1 Diabetes Prevention

Hahl, Jarmo, Simell, Tuula, Kupila, Antti, Keskinen, P??ivi, Knip, Mikael, Ilonen, Jorma, Simell, Olli

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 160 KB

english, 2003

6

Factors Affecting UK Primary-Care Costs of Managing Patients with Asthma over 5 Years

Das Gupta, Roben, Guest, Julian F.

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 204 KB

english, 2003

7

The Cost Effectiveness of Two New Antiepileptic Therapies in the Absence of Direct Comparative Data

van Hout, Ben A., Gagnon, Dennis D., Mcnulty, Pauline, O??Hagan, Anthony

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 184 KB

english, 2003